EFFECT OF INTRA-ARTICULAR INJECTION FOLLOWING ARTHROCENTESIS IN PATIENTS WITH TEMPOROMANDIBULAR DISORDERS
Phase 4
- Conditions
- Health Condition 1: M266- Temporomandibular joint disorders
- Registration Number
- CTRI/2023/09/058144
- Lead Sponsor
- Subhathraa G
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
o Patients who presented to the OPD of Department of Oral and Maxillofacial Surgery of Sri Ramachandra Institute of Higher Education and Research.
o Patients with TMD [Wilke’s Staging 3, 4, 5 and Wilke’s 1, 2 (Failed to respond to conservative
management)]
o Patients who were willing for investigations and treatment procedure
Exclusion Criteria
o Patients without TMD
o Patients who were not willing for further investigations and treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie hyaluronic acid and i-PRF effects in TMJ disorders?
How does hyaluronic acid compare to corticosteroids in TMJ treatment effectiveness?
Are there specific biomarkers that predict response to i-PRF in temporomandibular joint disorders?
What are the potential adverse events associated with intra-articular i-PRF injections for TMJ?
What combination therapies show promise with hyaluronic acid for temporomandibular disorders?